about
Post-transcriptional dysregulation by miRNAs is implicated in the pathogenesis of gastrointestinal stromal tumor [GIST]Serum microRNA signatures identified by Solexa sequencing predict sepsis patients' mortality: a prospective observational studyData submission and quality in microarray-based microRNA profilingMicroRNA and signal transduction pathways in tumor radiation responseClassification of Indeterminate Melanocytic Lesions by MicroRNA Profiling.3'LIFE: a functional assay to detect miRNA targets in high-throughputGain-of-function microRNA screens identify miR-193a regulating proliferation and apoptosis in epithelial ovarian cancer cells.The miRNA and mRNA Signatures of Peripheral Blood Cells in Humans Infected with Trypanosoma brucei gambienseProfiling the circulating miRNAs in mice exposed to gram-positive and gram-negative bacteria by Illumina small RNA deep sequencingMicroRNA-193b-3p acts as a tumor suppressor by targeting the MYB oncogene in T-cell acute lymphoblastic leukemiaDetection of miRNA Targets in High-throughput Using the 3'LIFE AssayMiR-193b promotes autophagy and non-apoptotic cell death in oesophageal cancer cellsEpigenetically altered miR-193b targets cyclin D1 in prostate cancerMicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid MalignanciesThe role of miR-18b in MDM2-p53 pathway signaling and melanoma progressionLong noncoding RNA MIR31HG exhibits oncogenic property in pancreatic ductal adenocarcinoma and is negatively regulated by miR-193bMicroRNAs in the pathogenesis of malignant melanoma.MicroRNA and cutaneous melanoma: from discovery to prognosis and therapy.Aberrations in the micro-RNA biogenesis machinery and the emerging roles of micro-RNAs in the pathogenesis of cutaneous malignant melanoma.Ion channels/transporters as epigenetic regulators? -a microRNA perspective.miR in melanoma development: miRNAs and acquired hallmarks of cancer in melanoma.microRNAs in cancer cell response to ionizing radiation.Oncogenic and tumor suppressive roles of microRNAs in apoptosis and autophagy.Melanoma epigenetics: novel mechanisms, markers, and medicines.MicroRNAs and photocarcinogenesis.Pivotal MicroRNAs in Melanoma: A Mini-Review.Experimental verification of a conserved intronic microRNA located in the human TrkC gene with a cell type-dependent apoptotic function.Functional Annotation of Metastasis-associated MicroRNAs of Melanoma: A Meta-analysis of Expression Profiles.CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancer.Stathmin 1 is a potential novel oncogene in melanoma.Born to be alive: a role for the BCL-2 family in melanoma tumor cell survival, apoptosis, and treatmentConjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.miR-193b Modulates Resistance to Doxorubicin in Human Breast Cancer Cells by Downregulating MCL-1.Anti-cancer drug discovery and development: Bcl-2 family small molecule inhibitors.A c-Myc-MicroRNA functional feedback loop affects hepatocarcinogenesis.The involvement of lncRNAs in the development and progression of pancreatic cancer.Serum microRNA-193b as a promising biomarker for prediction of chemoradiation sensitivity in esophageal squamous cell carcinoma patients.Deregulation of microRNA-193b affects the proliferation of liver cancer via myeloid cell leukemia-1.LINC00152 down-regulated miR-193a-3p to enhance MCL1 expression and promote gastric cancer cells proliferation.Downregulation of miR-193b in systemic sclerosis regulates the proliferative vasculopathy by urokinase-type plasminogen activator expression.
P2860
Q21133528-00545763-9C52-4559-A19D-D9117FF43F93Q21134526-2991EB4E-903C-4818-AE12-A725357DB0D6Q24282608-25A2012B-3F00-4E03-A382-7527D1F53E05Q27027546-B4EDE808-A039-42C0-8718-FF5177C4604EQ30276253-16EEEE8B-E8E0-43C5-AED8-EBB2A6C451EAQ34248768-DACDA637-B7DC-4648-B222-E151FEE7D6F4Q34669761-053E6CF9-5C55-493F-87C1-E35297A88505Q34796896-3DEEF270-C73E-4DFB-BFEA-C8250186A2E5Q34988918-DEE54A78-D900-4465-B64B-CD63CE22FCD9Q35260085-65036FF3-60B2-4568-AEBB-5330C6CF426AQ35661330-AD63957F-252C-4273-AB78-456F38374738Q35924139-D8136DDE-CF6B-49B8-92BB-CB5D31AFF4D0Q36051801-065DE1E9-F493-4827-A3F0-87748037EAFCQ36602853-F45FEAA1-2A45-4729-A527-1D9D5BC8FEA1Q36697766-3BC44777-4DC8-40A6-A4FF-2AA2D71066FCQ37100568-EF4B28FE-8F74-47BF-9A52-BBE9B06E16E5Q38012532-5359EDCC-51F3-40C1-AEDE-7F0ADA0E158FQ38018308-527FD048-D89A-4415-9542-EB8732007FD6Q38041704-544958D3-8DC8-4ACB-8DE7-D7E5ECA98E98Q38046769-32B25AFD-9ABC-432E-A57F-3E29BD240229Q38138933-2EA7A42A-D75E-404C-8689-547D6A6B6FDFQ38160950-72FCF171-3440-4CB8-BC0C-AF511F884AD3Q38213627-68B12E45-62CF-42CB-99DB-973319E36466Q38224624-570038AA-7036-4048-91D9-7BC4443140F3Q38250171-040F7FE9-14AF-4BD5-9E9C-9474BFBA471FQ38879511-1F3F115C-8ED4-4040-BF6F-3B4838BCC473Q38899793-534FE6FF-84C2-4CF7-8223-8007A8CA064DQ39283596-174D708D-547E-4391-893F-244636A5F4F0Q39314424-C38E9BC9-67D0-43D5-8CF4-D4A5A28149D4Q39337144-59269CCC-C7FD-492E-857E-6305E5742B29Q39661214-C26A223D-F7F5-4F34-8308-6E4606F7DF1EQ39756781-826ADF32-35FD-435E-81B7-D445AEF6E41EQ41998563-C0435748-1419-45BC-93F8-0220B14CF134Q42061450-1C690276-BEE5-445A-ACD0-CF7544807CD1Q44714902-5CC21FA3-3DA4-4877-BFDF-A3FB81D8393CQ47624410-E75ABC0C-BD0D-4E91-A2F5-2FA7E7E9D334Q49587519-FDBE634B-84B4-4268-8285-42DEBB37D4F9Q49740320-C9A52EF5-D7C0-49A9-88F7-2E2D113FF854Q50020595-F08B74D0-A831-40CE-9DE1-FB0AA4D80331Q51684920-000AB8DC-F741-41A6-AD9C-1F5E5328F8F6
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
miR-193b Regulates Mcl-1 in Melanoma.
@ast
miR-193b Regulates Mcl-1 in Melanoma.
@en
type
label
miR-193b Regulates Mcl-1 in Melanoma.
@ast
miR-193b Regulates Mcl-1 in Melanoma.
@en
prefLabel
miR-193b Regulates Mcl-1 in Melanoma.
@ast
miR-193b Regulates Mcl-1 in Melanoma.
@en
P2093
P2860
P1476
miR-193b Regulates Mcl-1 in Melanoma.
@en
P2093
Cindy Lentz
Geneviève C Paré
Harriet E Feilotter
Jiamin Chen
Marie Abi-Daoud
Victor A Tron
Xiao Zhang
Xiaolong Yang
P2860
P304
P356
10.1016/J.AJPATH.2011.07.010
P407
P577
2011-09-03T00:00:00Z